Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Hepatitis C treatment numbers fell sharply in 2020

By Mindo - 06th Apr 2021 | 36 views

The numbers of people who commenced curative direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) dropped sharply to 532 last year, compared to 1,196 in 2019.

A spokesperson for the HSE National Hepatitis C Treatment Programme (NHCTP) told the Medical Independent (MI) that treatment numbers had been affected by the Covid-19 pandemic.

“This is mainly due to the disruption of primary care and the reduction in outpatient numbers in hospital,” said a spokesperson. “However, the NHCTP has remained open since the start of the Covid-19 pandemic and new patients continued to be assessed and treated. There were some delays in receiving PCR and genotyping results in the early period of the pandemic, but these have been resolved and treatment numbers are now increasing.”

The NHCTP informed MI the target for 2021 “is to seek and treat as many as possible”.

Ireland has committed to the World Health Organisation HCV elimination targets by 2030. However, clinicians and community workers have warned that more efforts are required to ensure treatment access for the most difficult to reach patients. Most diagnosed cases are in people who currently, or formerly, injected drugs.

HCV can be asymptomatic or mildly symptomatic for many years.

Ms Nicola Perry, Manager at Community Response, which works extensively on improving HCV treatment access, said HCV elimination required a multifaceted, multidisciplinary approach based in community settings.

See news feature, Walking the hard road to HCV elimination – Medical Independent

Leave a Reply

Latest
Latest Issue
The Medical Independent 30th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read